Alice Castello, Italy

Fabrizio Caldera

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fabrizio Caldera: Innovator in Drug Delivery Systems

Introduction

Fabrizio Caldera is a notable inventor based in Alice Castello, Italy. He has made significant contributions to the field of drug delivery systems, particularly through his innovative use of cross-linked starch-based materials. With a total of three patents to his name, Caldera's work focuses on enhancing the oral administration of biological actives.

Latest Patents

Caldera's latest patents include "Cross-linked maltodextrins for the oral delivery of biological actives." This invention relates to the oral administration of biological actives, specifically insulin, utilizing a cross-linked starchy material as a delivery system. Another significant patent is "Cross-linked starch-based polymers for drug delivery." This invention outlines a process for preparing a cross-linked starch-based polymer, which involves dissolving a starchy material in a suitable solvent and adding an episulfide to create a disulfide cross-linked polymer characterized by disulfide bridges.

Career Highlights

Throughout his career, Fabrizio Caldera has worked with prominent companies such as Roquette Frères and Roquette Italia S.p.a. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of drug delivery.

Collaborations

Caldera has collaborated with notable colleagues, including Francesco Trotta and Roberta Cavalli. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Fabrizio Caldera's work in the field of drug delivery systems showcases his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to enhancing the efficacy of oral administration of biological actives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…